510(k) device
CoaguChek XS Pro System
Roche Diagnostics · Test, Time, Prothrombin (GJS, Class II) · First FDA decision Mar 18, 2010, newest Apr 19, 2018Anemia, clotting and blood disordersStroke prevention in atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
0
Naming "CoaguChek XS Pro"
MAUDE reports
15
Brand "CoaguChek XS Pro", since 2015
PubMed studies
10
Mentioning "CoaguChek XS Pro"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing CoaguChek XS Pro System
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- CoaguChek XS Pro System510(k)
K180693 · Decided Apr 19, 2018 · 34 days after receipt
Device type: Test, Time, Prothrombin (GJS) · Laboratory Medicine & Pathology
- COAGUCHEK XS PRO SYSTEM510(k)
K093460 · Decided Mar 18, 2010 · 132 days after receipt
Device type: Test, Time, Prothrombin (GJS) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Home Prothrombin Time/International Normalized Ratio (PT/INR) Monitoring for Anticoagulation ManagementNational determinationOn the books190.11Updated Nov 4, 2026
- Prothrombin Time (PT)National determinationOn the books190.17Updated Oct 1, 2026
- Prothrombin Time (INR) Monitor for Home Anticoagulation ManagementNational analysisReview closedCAG-00087RUpdated Sep 21, 2026
- Prothrombin Time and Partial Thromboplastin Time (Revision of ICD-9-CM Codes for Swelling of Limb)Coding analysisReview closedCAG-00201NUpdated Sep 15, 2026
- Prothrombin Time and Partial Thromboplastin Time (Revision of ICD-9-CM Codes for Pre-operative Examinations)Coding analysisReview closedCAG-00184NUpdated Sep 15, 2026
- Prothrombin Time and Fecal Occult Blood (Revision of ICD-9-CM Codes for Injury to Gastrointestinal Tract)Coding analysisReview closedCAG-00187NUpdated Sep 15, 2026
- Prothrombin Time (PT) NCD 190.17 (Addition of ICD-9-CM diagnosis code 197.7 Secondary Malignant Neoplasm of Liver)Coding analysisReview closedCAG-00404NUpdated Sep 15, 2026
- Prothrombin Time (PT) and Partial Thromboplastin Time (PTT) tests (Removal of Unspecified Joint Replacements)Coding analysisReview closedCAG-00246NUpdated Sep 15, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "CoaguChek XS Pro", any status and sponsor, newest update first.
No registered device study names "CoaguChek XS Pro".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "CoaguChek XS Pro", and for the whole product code for context.
This brand
15 reports: 15 malfunction, 0 injury, 0 death
Whole product code GJS
12,207 reports: 11,507 malfunction, 644 injury, 34 death
Newest reports for this brand
- COAGUCHEK XS PRO KITMalfunction
1823260-2021-01211 · Received Apr 22, 2021 · Event dated Mar 30, 2021
Device type: Test, Time, Prothrombin (GJS)
Device problem as coded: Image Display Error/Artifact
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- COAGUCHEK XS PRO KIT INTERNATIONALMalfunction
1823260-2021-00625 · Received Mar 2, 2021 · Event dated Feb 5, 2021
Device type: Test, Time, Prothrombin (GJS)
Device problem as coded: Circuit Failure
Patient problem as coded: No Consequences Or Impact To Patient
- COAGUCHEK XS PRO KIT INTERNATIONALMalfunction
1823260-2020-02707 · Received Oct 30, 2020 · Event dated Oct 5, 2020
Device type: Test, Time, Prothrombin (GJS)
Device problem as coded: Display or Visual Feedback Problem
Patient problem as coded: No Consequences Or Impact To Patient
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0360-2019 · Started Sep 13, 2018 · Posted by FDA Nov 2, 2018
Reason given: Abnormally high INR test results with the affected CoaguChek test strips
Cause as FDA categorized it: Nonconforming Material/Component · Device type: Test, Time, Prothrombin (GJS)
Roche Diagnostics Operations, Inc.
Z-1582-2013 · Started May 16, 2013 · Posted by FDA Jun 24, 2013
Reason given: Roche has confirmed the potential for an undetected elevated INR test result with the CoaguChek XS, CoaguChek XS Plus, and CoaguChek XS Pro meters. In rare cases, instead of a value, an ERROR 6 message is displayed.
Cause as FDA categorized it: Software design · Device type: Test, Time, Prothrombin (GJS)
Roche Diagnostics Operations, Inc.
Z-1114-2013 · Started Mar 6, 2013 · Posted by FDA Apr 15, 2013
Reason given: Roche investigation into complaints found Accu-Chek Inform II and CoaguChek XS Pro System barcode reading meters had the potential of intermittent erroneous decoding of patient identification if barcodes being read fail to meet size and/or quality standards. Errors have been confirmed with the EAN 13 barcodes which...
Cause as FDA categorized it: Device Design · Device type: Test, Time, Prothrombin (GJS)
Published research
The most relevant PubMed records for "CoaguChek XS Pro"[tiab]. The summary above synthesizes these.
- CoaguChek and Coag-Sense PT2 Meter Point of Care INR Device Validation.
McBane RD, O'Connor C, Lutz J, et al. · Mayo Clin Proc · 2024Multicenter Study, Validation Study
- Accuracy and Precision of Point-of-Care International Normalized Ratio in Patients With Liver Disease.
Shadlyn T, Bauman M, Tandon P, et al. · J Pediatr Gastroenterol Nutr · 2023
- Preclinical evaluation of point-of-care prothrombin time as a biomarker test to guide prothrombin replacement therapy in coagulopathic bleeding.
Balendran CA, Henderson N, Olsson M, et al. · Res Pract Thromb Haemost · 2017
- Clinical evaluation of laboratory methods to monitor exposure of rivaroxaban at trough and peak in patients with atrial fibrillation.
Al-Aieshy F, Malmström RE, Antovic J, et al. · Eur J Clin Pharmacol · 2016Clinical Trial
- Prospective Comparison of Point-of-Care Device and Standard Analyzer for Monitoring of International Normalized Ratio in Outpatient Oral Anticoagulant Clinic.
Moiz B, Rashid A, Hasan M, et al. · Clin Appl Thromb Hemost · 2018
- Bluetooth enabled point-of-care INR device validation for warfarin management.
McBane RD, Lutz J, O'Connor C, et al. · Thromb Res · 2026Multicenter Study, Research Support, Non-U.S. Gov't
- Level of agreement between laboratory and point-of-care prothrombin time before and after cardiopulmonary bypass in cardiac surgery.
Meesters MI, Vonk AB, van de Weerdt EK, et al. · Thromb Res · 2014Research Support, Non-U.S. Gov't
- Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs).
Padayattil Jose S, Banzato A, Carraro P, et al. · Thromb Res · 2018
- [Management of traumatic coagulopathy during long-distance medical evacuation: utility of the Coaguchek(®) XS pro].
Cotte J, Lacroix G, D'Aranda E, et al. · Ann Fr Anesth Reanim · 2013Case Reports, Letter
- Point-of-Care Coagulation Testing for Trauma Patients in a Military Setting: A Prospective Study.
Cotte J, d'Aranda E, Chauvin V, et al. · J Spec Oper Med · 2013
Other devices of this type
Also filed under product code GJS.
- microINR SystemIline Microsystems, S.L. · 510(k) 2025
- CoaguChek XS Plus SystemRoche Diagnostics · 510(k) 2025
- Coag-Sense Prothrombin (PT) / INR Monitoring System for Patient Self-TestingCoagusense, Inc. · 510(k) 2022
- Hemosil Recombiplastin 2G (8 Ml Vial)Instrumentation Laboratory CO · 510(k) 2014
- Coaguchek Xs SystemRoche Diagnostics Corp. · 510(k) 2007
- Xprecia Prime Coagulation SystemUniversal Biosensors Pty, Ltd. · 510(k) 2024
- i-STAT PTplus Cartridge with the i-STAT 1 SystemAbbott Laboratories · 510(k) 2023
- STA- NeoPTimalDiagnostica Stago S.A.S · 510(k) 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.